ESE 0.00% 1.8¢ esense-lab ltd

Ann: Terpenes Formulation Shows Signs of Cellular Growth Arrest, page-2

  1. 1,351 Posts.
    lightbulb Created with Sketch. 142
    This company confuses me. I really have no idea what they are trying to achieve, and looking over all their recent announcements I'm not sure if they know themselves. From the IPO documents it certainly wasn't clear this stock would become a speculative biopharma...

    Such a shame the board challengers didn't get the votes.
 
watchlist Created with Sketch. Add ESE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.